Wanbury - Limited Review for the quarter ended Jun 30, 2008
Wanbury Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2008.12-09-2008
12-09-2008
Wanbury - E-mail ID for Investors Complaints
Wanbury Ltd has informed BSE that the email ID for the purpose of registering complaints by investors is shares@wanbury.com04-09-2008
Wanbury - Notice of Postal Ballot
Wanbury Ltd has informed BSE that the members of the Company will consider to approve by way of Postal ballot the Special Resolution:1. To make investment (s) in Share (s) / Security (ies) of (a) a wholly owned subsidiary (WOS) company to be incorporated in India (therefore the specific name of WOS is not being given) and (b) a wholly owned subsidiary company to be incorporated in a Tax Free Zone, in the Middle East (therefore the specific name is not being given) and / or...20-08-2008
Wanbury - Updates on Scheme of Merger & Intimation of Board Meeting
Wanbury Ltd has informed BSE that the Hon'ble Supreme Court has given an Order dated May 16, 2008 in the matter of merger of The Pharmaceutical Products of India Ltd (PPIL) with Wanbury Ltd (the Company). The Company has received the Certified True Copy of the said order on June 11, 2008.Further the Company has informed BSE that a meeting of the Board of Directors of the Company will be held on June 27, 2008, inter alia, to consider the Unaudited...19-06-2008
Wanbury - Updates
Wanbury Ltd has informed BSE that the Company has received an Award for "Best Launch of the year" for its formulation product "C Pink", an iron supplement for treatment of anemia, from ORG IMS.07-05-2008
Wanbury - FY 08 results by Jun 30, 2008
Wanbury Ltd has informed BSE that the Company has taken the decision for publishing Audited Financial Result for the Financial Year ended as on March 31, 2008 on or before June 30, 2008.Therefore the Company is not publishing the Unaudited Financial Results for last quarter ended as on March 31, 2008.28-04-2008
Wanbury - Outcome of Board Meeting
Wanbury Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2008, inter alia, have approved the appointment of Mr. Hemant V Shah as Cost Auditor of the Company for the Financial Year 2008-2009.28-04-2008
Wanbury - Board meeting on Apr 28, 2008
Wanbury Ltd has informed BSE that a meeting of Board of Directors of the Company will be held, on April 28, 2008, inter alia, to consider the appointment of Cost Auditor for the financial year 2008-2009.23-04-2008
Wanbury - Allotment of equity shares
Wanbury Ltd has informed BSE that 7,85,557 equity shares of the Company, have been allotted to the equity shareholders of Doctors Organic Chemicals Ltd, pursuant to the Order of Hon'ble Board for Industrial and Financial Reconstruction (BIFR), Delhi.17-03-2008
Wanbury - Limited Review for the quarter ended Dec 31, 2007
Wanbury Ltd has informed BSE that in the limited review report of the Company for the quarter ended December 31, 2007, the Auditors of the Company have made the following observations :"As stated in note no. 6 of the statement of unaudited financial results, the results for the quarter ended December 31, 2007 do not take into consideration the effect of adjustments required to be carried out in accordance with the requirements of Accounting...29-02-2008